HYPERSTAT Drug Patent Profile
✉ Email this page to a colleague
When do Hyperstat patents expire, and what generic alternatives are available?
Hyperstat is a drug marketed by Schering and is included in one NDA.
The generic ingredient in HYPERSTAT is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hyperstat
A generic version of HYPERSTAT was approved as diazoxide by E5 PHARMA INC on December 20th, 2019.
Summary for HYPERSTAT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Patent Applications: | 3,831 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYPERSTAT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HYPERSTAT
US Patents and Regulatory Information for HYPERSTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | HYPERSTAT | diazoxide | INJECTABLE;INJECTION | 016996-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |